Delphi Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Delphi Management's NVS Position: Q1 2026 in Review
Delphi Management reduced its Novartis (NVS) stake by 32% in Q1 2026, selling an estimated $573K and leaving 7,988 shares worth $1.22M. The position accounts for 1.46% of the portfolio, ranked #22.
Delphi Management first reported a position in NVS in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.8M in Q2 2024. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Delphi Management held 7,988 shares of Novartis worth $1.22M as of Q1 2026.
- Delphi Management sold 3,735 Novartis shares in Q1 2026, an estimated $573K.
- Novartis made up 1.46% of Delphi Management's portfolio in Q1 2026, its #22 holding.
- Delphi Management first reported a position in Novartis in Q1 2021 and has held it in 17 quarters since.
- Delphi Management's Novartis position peaked at $1.8M in Q2 2024.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Delphi Management's 13F filing for Q1 2026, filed 20 Apr 2026.